isavuconazole (Cresemba®)
Application Details
HSE100027
25016
isavuconazole
Cresemba®
Pfizer Healthcare Ireland
05/03/2025
22/08/2024
Application Status
HSE Approval Letter Issued to Applicant
01/11/2025
Reviewed by HSE Senior Leadership Team
07/10/2025
Reviewed by HSE Drugs Group
09/09/2025
HSE Drugs Group Review Pending
24/06/2025
Proposal from Applicant Under Review
23/06/2025
Awaiting Proposal from Applicant
15/05/2025
Applicant Meeting Held with CPU
15/05/2025
Rapid Review Completed
25/03/2025
Pricing and Reimbursement Application Complete
05/03/2025
Rapid Review Commissioned
26/02/2025